AWM Investment Company »

Alpine Immune Sciences shares owned by AWM Investment Company

Quarter-by-quarter ownership of Alpine Immune Sciences (ALPN) shares owned by AWM Investment Company from 13F filings

Historical chart of AWM Investment Company investment in Alpine Immune Sciences

Tip: Access up to 7 years of quarterly data

All positions including Alpine Immune Sciences held by AWM Investment Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Alpine Immune Sciences by AWM Investment Company

Quarter filed Position value Share count Share price at filing
2023-12-31 $762k 40k 19.06

More positions owned by AWM Investment Company

Destination XL Group common (DXLG)
Aspen Aerogels common (ASPN)
Aehr Test Systems common (AEHR)
Impinj common (PI)
ADMA Biologics common (ADMA)
American Superconductor Corpor common (AMSC)
Infusystem Holdings common (INFU)
Everspin Technology common (MRAM)
Repligen Corporation common (RGEN)
Kopin Corporation common (KOPN)
Leonardo DRS common (DRS)
Arbe Robotics common (ARBE)
Ooma common (OOMA)
Universal Technical Institute common (UTI)
Aerovironment common (AVAV)

View all positions for AWM Investment Company

Top funds holding Alpine Immune Sciences

Decheng Capital
RA Capital Management
Lynx1 Capital Management
Dr. Jeffrey R. Jay, M.D.
Paradigm Biocapital Advisors
Frazier Life Sciences Management
Cormorant Asset Management
OrbiMed Advisors
Vanguard Group
T. Rowe Price Associates
Commodore Capital
Octagon Capital Advisors
Franklin Resources
Citadel Advisors
Henderson Group

View all funds holding Alpine Immune Sciences